Portosystemic Shunt
6
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Portosystemic Shunt-associated Pulmonary Hypertension Multi-center Prospective Cohort Study
Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
Efficacy and Safety of EUS-Guided Therapy Versus BRTO for Gastric Varices With Shunt
To Compare the Outcome of Temporary Portocaval Shunt During Recipient Hepatectomy Versus No Shunt in Adult Elective Live Donor Liver Transplantation.
Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication